Skip to main content
Erschienen in: Journal of Medical Systems 3/2021

01.03.2021 | Systems-Level Quality Improvement

Event Surrogate from Clinical Pathway Completion to Daily Meal for Availability Extension Using Standard Electronic Medical Records: a Retrospective Cohort Study

verfasst von: Hiroki Furuhata, Kenji Araki, Taisuke Ogawa

Erschienen in: Journal of Medical Systems | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to improve generalizability of our previous study that analyzed clinical pathway (CP) completion. Although our previous study demonstrated that CP completion can reduce the length of hospital stay, it is possible for few medical organizations to extract the implementation of treatment registered on CP from typical electronic medical records. Therefore, we have defined a prospective event for event substitution, called meal completion (MC), in which patients can take their meal daily. Data were collected from April 2013 to March 2018 from the electronic medical records of the University of Miyazaki Hospital. We used propensity score matching to extract records from 8033 patients. Patients were further divided into the MC and non-MC groups; 2577 patients in each group were available for data analysis. The numbers of patients with CP completion were 646 (28.1%) in the MC group and 411 (18.2%) in the non-MC group. The P value of the chi-square test was <0.001. According to this result, there was the causation from MC to increase in CP completion. Additionally, it was possible to consider the inclusion relationship in all treatments (universal set), treatments registered on CP (subset of all treatments), and meals (subset of treatments registered on CP). In conclusion, MC can substitute for CP completion because the demonstration is appropriate for the Prentice criterion, which is often used for the evaluation of a surrogate endpoint.
Literatur
8.
Zurück zum Zitat Kanehira, T., Sugihara, T., Suzuki, M., Gofuku, A., Araki, K., Exploring Risk-Benefit Factors of Electronic Clinical Pathways Regarding Nursing Communication. In: Duffy V. (eds) Digital Human Modeling: Applications in Health, Safety, Ergonomics and Risk Management. DHM 2016. Lecture Notes in Computer Science, vol 9745. Springer, Cham. https://doi.org/10.1007/978-3-319-40247-5_43, (2016) Kanehira, T., Sugihara, T., Suzuki, M., Gofuku, A., Araki, K., Exploring Risk-Benefit Factors of Electronic Clinical Pathways Regarding Nursing Communication. In: Duffy V. (eds) Digital Human Modeling: Applications in Health, Safety, Ergonomics and Risk Management. DHM 2016. Lecture Notes in Computer Science, vol 9745. Springer, Cham. https://​doi.​org/​10.​1007/​978-3-319-40247-5_​43, (2016)
13.
15.
Zurück zum Zitat Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89-95.CrossRef Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89-95.CrossRef
16.
Zurück zum Zitat Prentice RL. (1989). Surrogate endpoints in clinical trials: Definition and operational criteria. Stat Med 8:431-440.CrossRef Prentice RL. (1989). Surrogate endpoints in clinical trials: Definition and operational criteria. Stat Med 8:431-440.CrossRef
17.
Zurück zum Zitat Freedman, L. S., Graubard B.I. (1992) Statistical validation of intermediate endpoints for chronic diseases. Stat Med 11:167-178.CrossRef Freedman, L. S., Graubard B.I. (1992) Statistical validation of intermediate endpoints for chronic diseases. Stat Med 11:167-178.CrossRef
18.
Zurück zum Zitat Buyse M, Molenberghs G (1998) Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics 54:1014-1029.CrossRef Buyse M, Molenberghs G (1998) Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics 54:1014-1029.CrossRef
19.
Zurück zum Zitat Daniels MJ, Hughes MD (1997) Meta-analysis for the evaluation of potential surrogate markers. Stat Med 16:1965-1982.CrossRef Daniels MJ, Hughes MD (1997) Meta-analysis for the evaluation of potential surrogate markers. Stat Med 16:1965-1982.CrossRef
23.
Zurück zum Zitat Todd PE (2001) Reconciling Conflicting Evidence on the Performance of Propensity-Score Matching Methods. Am Econ Rev 91:112-118.CrossRef Todd PE (2001) Reconciling Conflicting Evidence on the Performance of Propensity-Score Matching Methods. Am Econ Rev 91:112-118.CrossRef
Metadaten
Titel
Event Surrogate from Clinical Pathway Completion to Daily Meal for Availability Extension Using Standard Electronic Medical Records: a Retrospective Cohort Study
verfasst von
Hiroki Furuhata
Kenji Araki
Taisuke Ogawa
Publikationsdatum
01.03.2021
Verlag
Springer US
Erschienen in
Journal of Medical Systems / Ausgabe 3/2021
Print ISSN: 0148-5598
Elektronische ISSN: 1573-689X
DOI
https://doi.org/10.1007/s10916-021-01714-x

Weitere Artikel der Ausgabe 3/2021

Journal of Medical Systems 3/2021 Zur Ausgabe